Biotech companies are making monumental strides in cancer treatment, leveraging cutting-edge technologies to redefine the ...
BofA reinstated coverage of Gilead (GILD) with a Buy rating and $109 price target The investment case is “simple,” namely that Gilead is a ...
In a report released today, Geoff Meacham from Citi maintained a Buy rating on Gilead Sciences (GILD – Research Report). The company’s shares ...
AstraZeneca and Gilead are both staying tight-lipped over rumoured merger talks, but the consensus among analysts seems to be that there would anyway be little value in such a deal. On Sunday ...
A New South Wales man has avoided jail time after becoming the first person charged under the state's new coercive control laws.
Crypto Ecosystem Is Shifting from Users to Owners, says Consensys ...
Talks between British Prime Minister Sir Keir Starmer and Cypriot President Nikos Christodoulides in Nicosia centered on the Middle East crisis and the Cyprus settlement process. Starmer, the first ...